138 related articles for article (PubMed ID: 32319583)
1. Mast cell chymase promotes angiogenesis and lymphangiogenesis mediated by activation of melanoma inhibitory activity gene family members in oral squamous cell carcinoma.
Kurihara-Shimomura M; Sasahira T; Shimomura H; Bosserhoff AK; Kirita T
Int J Oncol; 2020 May; 56(5):1093-1100. PubMed ID: 32319583
[TBL] [Abstract][Full Text] [Related]
2. Transport and Golgi organisation protein 1 is a novel tumour progressive factor in oral squamous cell carcinoma.
Sasahira T; Kirita T; Yamamoto K; Ueda N; Kurihara M; Matsushima S; Bhawal UK; Bosserhoff AK; Kuniyasu H
Eur J Cancer; 2014 Aug; 50(12):2142-51. PubMed ID: 24889917
[TBL] [Abstract][Full Text] [Related]
3. High mobility group box-1-inducible melanoma inhibitory activity is associated with nodal metastasis and lymphangiogenesis in oral squamous cell carcinoma.
Sasahira T; Kirita T; Oue N; Bhawal UK; Yamamoto K; Fujii K; Ohmori H; Luo Y; Yasui W; Bosserhoff AK; Kuniyasu H
Cancer Sci; 2008 Sep; 99(9):1806-12. PubMed ID: 18616526
[TBL] [Abstract][Full Text] [Related]
4. A comprehensive expression analysis of the MIA gene family in malignancies: MIA gene family members are novel, useful markers of esophageal, lung, and cervical squamous cell carcinoma.
Sasahira T; Kirita T; Nishiguchi Y; Kurihara M; Nakashima C; Bosserhoff AK; Kuniyasu H
Oncotarget; 2016 May; 7(21):31137-52. PubMed ID: 27145272
[TBL] [Abstract][Full Text] [Related]
5. Protumoral roles of melanoma inhibitory activity 2 in oral squamous cell carcinoma.
Kurihara M; Kirita T; Sasahira T; Ohmori H; Matsushima S; Yamamoto K; Bosserhoff AK; Kuniyasu H
Br J Cancer; 2013 Apr; 108(7):1460-9. PubMed ID: 23511560
[TBL] [Abstract][Full Text] [Related]
6. MIA-dependent angiogenesis and lymphangiogenesis are closely associated with progression, nodal metastasis and poor prognosis in tongue squamous cell carcinoma.
Sasahira T; Kirita T; Kurihara M; Yamamoto K; Bhawal UK; Bosserhoff AK; Kuniyasu H
Eur J Cancer; 2010 Aug; 46(12):2285-94. PubMed ID: 20570137
[TBL] [Abstract][Full Text] [Related]
7. The importance of melanoma inhibitory activity gene family in the tumor progression of oral cancer.
Sasahira T; Bosserhoff AK; Kirita T
Pathol Int; 2018 May; 68(5):278-286. PubMed ID: 29655307
[TBL] [Abstract][Full Text] [Related]
8. Mast cell chymase is present in uterine cervical carcinoma and it detaches viable and growing cervical squamous carcinoma cells from substratum in vitro.
Diaconu NC; Rummukainen J; Naukkarinen A; Mättö M; Harvima RJ; Pelkonen J; Harvima IT
Arch Dermatol Res; 2011 Sep; 303(7):499-512. PubMed ID: 21274549
[TBL] [Abstract][Full Text] [Related]
9. Sushi Repeat Containing Protein X-linked 2 Is a Downstream Signal of LEM Domain Containing 1 and Acts as a Tumor-Promoting Factor in Oral Squamous Cell Carcinoma.
Sasahira T; Kurihara-Shimomura M; Nishiguchi Y; Shimomura H; Kirita T
Int J Mol Sci; 2020 May; 21(10):. PubMed ID: 32455867
[TBL] [Abstract][Full Text] [Related]
10. Storkhead box 2 and melanoma inhibitory activity promote oral squamous cell carcinoma progression.
Sasahira T; Nishiguchi Y; Fujiwara R; Kurihara M; Kirita T; Bosserhoff AK; Kuniyasu H
Oncotarget; 2016 May; 7(18):26751-64. PubMed ID: 27050375
[TBL] [Abstract][Full Text] [Related]
11. Identification of oral squamous cell carcinoma markers MUC2 and SPRR1B downstream of TANGO.
Sasahira T; Kurihara-Shimomura M; Shimomura H; Bosserhoff AK; Kirita T
J Cancer Res Clin Oncol; 2021 Jun; 147(6):1659-1672. PubMed ID: 33620575
[TBL] [Abstract][Full Text] [Related]
12. WISP-1 promotes VEGF-C-dependent lymphangiogenesis by inhibiting miR-300 in human oral squamous cell carcinoma cells.
Lin CC; Chen PC; Lein MY; Tsao CW; Huang CC; Wang SW; Tang CH; Tung KC
Oncotarget; 2016 Mar; 7(9):9993-10005. PubMed ID: 26824419
[TBL] [Abstract][Full Text] [Related]
13. Altered immunohistochemical expression of mast cell tryptase and chymase in the pathogenesis of oral submucous fibrosis and malignant transformation of the overlying epithelium.
Yadav A; Desai RS; Bhuta BA; Singh JS; Mehta R; Nehete AP
PLoS One; 2014; 9(5):e98719. PubMed ID: 24874976
[TBL] [Abstract][Full Text] [Related]
14. Significance of oral cancer-associated fibroblasts in angiogenesis, lymphangiogenesis, and tumor invasion in oral squamous cell carcinoma.
Lin NN; Wang P; Zhao D; Zhang FJ; Yang K; Chen R
J Oral Pathol Med; 2017 Jan; 46(1):21-30. PubMed ID: 27229731
[TBL] [Abstract][Full Text] [Related]
15. Expression of vascular endothelial growth factor A, B, C, and D in oral squamous cell carcinoma.
Shintani S; Li C; Ishikawa T; Mihara M; Nakashiro K; Hamakawa H
Oral Oncol; 2004 Jan; 40(1):13-20. PubMed ID: 14662410
[TBL] [Abstract][Full Text] [Related]
16. Tumour cell-derived WNT5B modulates in vitro lymphangiogenesis via induction of partial endothelial-mesenchymal transition of lymphatic endothelial cells.
Wang SH; Chang JS; Hsiao JR; Yen YC; Jiang SS; Liu SH; Chen YL; Shen YY; Chang JY; Chen YW
Oncogene; 2017 Mar; 36(11):1503-1515. PubMed ID: 27593938
[TBL] [Abstract][Full Text] [Related]
17. Combined Analysis of Vascular Endothelial Growth Factor Expression with Cyclooxygenase-2 and Mast Cell Density in Oral Squamous Cell Carcinoma.
Akbarzadeh Baghban A; Taghavi N; Shahla M
Pathobiology; 2017; 84(2):80-86. PubMed ID: 27577989
[TBL] [Abstract][Full Text] [Related]
18. Heterogeneity of mast cells at multiple body sites. Fluorescent determination of avidin binding and immunofluorescent determination of chymase, tryptase, and carboxypeptidase content.
Weidner N; Austen KF
Pathol Res Pract; 1993 Mar; 189(2):156-62. PubMed ID: 8321743
[TBL] [Abstract][Full Text] [Related]
19. Hypoxia inducible factor-alpha expression correlates with vascular endothelial growth factor-C expression and lymphangiogenesis/angiogenesis in oral squamous cell carcinoma.
Liang X; Yang D; Hu J; Hao X; Gao J; Mao Z
Anticancer Res; 2008; 28(3A):1659-66. PubMed ID: 18630523
[TBL] [Abstract][Full Text] [Related]
20. Knocking-down of CREPT prohibits the progression of oral squamous cell carcinoma and suppresses cyclin D1 and c-Myc expression.
Ma J; Ren Y; Zhang L; Kong X; Wang T; Shi Y; Bu R
PLoS One; 2017; 12(4):e0174309. PubMed ID: 28369091
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
